Number of Shares
3.37 Mil
Current Holdings Value*
$141.83 Mil
% of Portfolio
6.5%
Total Estimate Gain
$22.83 Mil
% of Total Estimate Gain
10.61%

Paradigm Biocapital Advisors LP's Merus NV Holding Summary

As of 2025-03-31, Paradigm Biocapital Advisors LP held 3.37 Mil shares of Merus NV(MRUS), totaling $141.83 Mil. This investment constitutes 6.5% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 4.87% of the outstanding Merus NV(MRUS) stock.

The initial trade took place in 2022Q1. And since then Paradigm Biocapital Advisors LP has made 7 purchases of MRUS, at an average price of $44.05, for a total of 4.88 Mil shares. In addition, there have been 2 sales at an average price of $35.09 for 1.33 Mil shares. Based on historical transaction data and MRUS's current price of $53.82, Paradigm Biocapital Advisors LP's estimated gain on his MRUS holdings is $22.83 Mil, reflecting a 10.61% gain to date.

Paradigm Biocapital Advisors LP MRUS ($53.82) Holding Chart

Paradigm Biocapital Advisors LP MRUS ($53.82) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1